Observe Medical is a fast growing medtech company currently most recognised for development and distribution of the Sippi automated digital urine system. Our vision is to enable innovations to be commercialised on a global market for the benefit of society, healthcare professionals and patients.

With Sippi, the company’s prevalent current focus is on addressing the challenge of hospital acquired infection in healthcare facilities worldwide. Urinary tract infections are the number one hospital acquired complication for patients, and their treatment is a considerable burden to hospital staff and budgets. Overall, almost 3 million Europeans are infected every year from hospital acquired infections of all types.
Observe Medical’s intent is to continually grow our platform and portfolio to address these and other healthcare challenges, through ongoing R&D and acquisition strategies in line with our goals and vision. 

Management team

rune-2022-300x300px-svv

RUNE NYSTAD

CHIEF EXECUTIVE OFFICER

Prior to Observe Medical, Rune was the CEO of Biim Ultrasound. He has over 20 years of experience in global medtech and industrial technology from the Nordics, US, Germany, Ireland and Hong Kong, including Boston Scientific. Has previously been involved in multiple successful start-ups and over 30 product launches.

perarne-500px

PER ARNE NYGÅRD

CHIEF FINANCIAL OFFICER

Per Arne joined Observe Medical in 2019 and has broad experience having worked with finance functions across several industries. Prior to Observe Medical, he worked with listed companies such as Veidekke and Multiconsult.

Board of directors

TERJE BAKKEN

CHAIRMAN OF THE BOARD

Partner in Norwegian private equity company Reiten & Co, the largest shareholder in Navamedic. Extensive experience from private equity, management and consulting

KATHRINE GAMBORG ANDREASSEN

BOARD MEMBER

Chief Executive Officer of Navamedic since 2018. Comprehensive experience from marketing and executive positions within consumer health, i.a. from Novicus Pharma, Weifa and Orkla

SANNA RYDBERG

BOARD MEMBER

Currently CEO at Arcoma AB, Sweden, with approximately 20 years of experience from leading positions in life science industry, most recently as CEO of Eurofins BioPharma Product Testing Sweden AB and Head of Operations for Healthcare Northern Europe at Linde. Holds a bachelor’s degree in Analytical Chemistry from Uppsala University, Sweden.

LINE TØNNESSEN

BOARD MEMBER

Line Tønnessen, a Norwegian citizen, holds the position as Investment Director in Reiten & Co. Tønnessen currently sits on the Board of Directors of Vow Green Metals AS and Grilstad Holding AS and holds a Bachelor of
Business Administration from the BI Norwegian Business School, an MBA in Finance from the Norwegian School of Economics (NHH), and is a Certified Financial Analyst (CFA).

ESKILD ENDRERUD

BOARD MEMBER

Eskild Endrerud, a Norwegian citizen, holds the position as CEO and Chairman of the Board of Seed Capital AS, a family-owned investment company. Endrerud has previously been Chairman of the Board and CFO of Biim Ultrasound AS which now is a part of Observe Medical ASA. Endrerud holds a BSc in Entrepreneurship and Business from BI Norwegian Business School, as well as a Master in Real Estate Development from NMBU Norwegian Business School.